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Ten men (35-49 years old) underwent lower body negative
pressure (LBNP)exposuresbefore end after 10d of continuous6"
head-down bedrest in orderto predict the eflect of weightlessness
on the responsivenessof leg vosculotureIo on orthostallcstress.
Heart rote (HR),mean arterial blood pressure(MAP). and imped-
ance rheogrophtc indices of orteflol pulse volume (APV) of the
legs were measured during resl and al 1 mln Of -30 mm Hg LBNP.
Bedresl-lnduced deconditlonlng was manifested by decreases
(p < 0,05) In plasma volume (17%). peak oxygen uplaRe (t6%),
and LBNPtolerance (17%). RestingHR was unchanged after be-
drest, but HR was higher (p < 0.05) at t rain at -30 mm Hg LBNP
after, compared with before, bedrest. Responsesof MAP to --30
mm Hg LBNPwere nol altered by bedrest. Resting APV was de-
creased (p < 0.05) by slmuloted weightlessness.However, APV
was reduced (p < 0.05) from rest lo I mln -30 mm Hg LBNPby the
same relative magnitude before and after bedrest (-21.4 + 3.4%
and -20.5 + 2.7%, respectively), We conclude thai peripheral
arterial vasoconslrlction, as Indicaled by reductions InAPVdurlng
LBNP,was nol affected by bedrest.Theseresultssuggestthat there
was no apparent alteration in responsivenessof the leg vosculo-
lure following simulated weightlessness.Therefore,it appears un-
likely that controlmechanisms of peripheral reslslancecontribute
significantly to reduced orthosfaIlc tolerance following space-
flight.
ARDIOVASCULAR ADAPTATION to weightlessness
occurs in manned spaceflight as well as in ground-
based simulation of microgravity (2,3,10,18-20). Adapta-
tion is accompanied by hypovolemia and orthostatic intol-
erance on return to Earth's normal gravitational forces. In
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an effort to understand the cause of deficient blood pressure
regulation during orthostasis at 1 G following prolonged
exposure to microgravity, investigators have sought possible
alterations in control mechanisms of cardiac and peripheral
hemodynamics. Data pertaining to alterations in cardiovas-
cular function after bedrest (simulated weightlessness) and
actual spaceflight are inconclusive. Identification of defects
in the control of peripheral vascular resistance during or-
thostasis after prolonged weightlessness might explain the
orthostatic intolerance observed in astronauts following
spacecraft reentry to the Earth's gravitational environment.
Orthostasis causes blood to be pooled in the lower extrem-
ities ( 1,13,15). Adequate control of leg .vasculature is essen-
tial for maintenance of arterial pressure tbllowing exposure
to weightlessness (2). Some investigators have suggested that
arterial and venous functions may be impaired lbllowing
adaptation to hypogravity 17,17,21). For example, herod-
dynamics of the legs may change following weightlessness;
this could be evident in alteration of vascular smooth muscle
response to adrenergic stimulation during orthostatic stress.
We examined changes in the arterial pulse volume (APV)
of the legs during exposure to lower body negative pressure
(LBNP) as an index of the vascular response to orthostatic
stress before and alter simulated weightlessness. We did this
in order to test the hypothesis that smooth muscle respon-
siveness would decrease in the arterial vasculature (7) tbl-
lowing simulated weightlessness.
METHODS
Ten healthy men with a mean (_S.E.) age of 39:1:2
years (range 35-49), a mean height of 178 ___2 cm (range
168-185), and a mean weight of 74.17 _+ 2.47 kg (range
64.04-92.87) gave written consent to participate as volun-
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teers. Subject selection was based on normal clinical results
of a screening evaluation consisting of a detailed physical
examination including a maximal treadmill stress test, a
pulmonary function test, a chest X-ray, complete blood
count, and urinalysis. No subject was taking medication at
the time of the study, and alcohol, cafl_ine, and exercise
were not allowed during the study.
Subjects spent 1 month undergoing familiarization testing
for all experimental procedures. The experiment included a
l-week ambulatory control period, followed by 10 d of 6°
head-down bedrest. All tests were conducted between 0730
and 1400 hours.
Subjects were exposed to LBNP on the third to sixth days
preceding bedrest and again at the end of bedrest. A 7-ml
blood sample was drawn from the antccubital vein of each
subject after instrumentation and placement into the plex-
iglass LBNP apparatus. After a 5-min supine resting control
period (PreLBNP), each subject underwent a graded LBNP
tolerance test. LBNP was first applied tbr 3-min at -30 mm
Hg, then -50 mm Hg for 5-min, and finally, additional
increments of-10 mm Hg for 5-rain each to a maximal
pressure of- 100 mm Hg or test termination. The temper-
ature inside the LBNP chamber was constant throughout
the experiment. The criteria for test termination were: a)
completion of 5-min at -100 mmHg; b) onset of presyn-
copal symptoms as indicated by a sudden bradycardia
greater than 15 bpm and/or a precipitous fall in systolic
blood pressure greater than 15 mm Hg between adjacent
30-s measurements; c) progressively decreased systolic blood
pressure to below 80 mm Hg; or d) voluntary subject
termination due to discomfort such as nausea or dizziness.
Peak LBNP tolerance was defined as the total time (in
minutes) of exposure to decompression prior to test termi-
nation. For comparison of hemodynamic responses before
and alter simulated weightlessness, we analyzed only meas-
urements taken I min alter initiating -30 mm Hg LBNP
because this was the longest exposure completed by all
subjects before and after bedrest.
Measurements of pulse resistances within the midthigh
leg segment were made during rest and l-min after initiation
of LBNP at -30 mm Hg. Subject instrumentation for these
measurements was as follows: a) electrodes were attached to
the foot, ankle, and midthigh region of each leg; b) addi-
tional spot electrodes were attached to the right and left
shoulders; c) the right and left leg and shoulder electrodes
were connected to form parallel segments; and d) multiple
length and circumference measurements were recorded be-
tween the midthigh and ankle electrodes which defined the
leg segment.
Indices of arterial pulse volume (APV) were measured
with a tetra-polar impedance plethysmograph (a modified
Beckman BR-100 Impedance Rheograph). The impedance
rheograph introduced a high frequency (100.4 kHz), low
amperage (0.7 mA R.M.S.) constant electrical current be-
tween the shoulder and foot electrodes. Simultaneous base-
line resistance and pulse resistance changes were measured
in the parallel leg segments between the ankle and midthigh
electrodes. Impedance measurements of baseline and pulse
resistances have shown proportionality to limb volumes and
APV, respectively (16). This impedance technique has dem-
onstrated a high correlation (r = 0.995) with the Whitney
strain plethysmographic method (12). The pulse resistance
measurements were used to calculate a mean APV, which
represented the average amount of blood that entered the
segment during each heartbeat and was used as an index of
the degree of arterial constriction (15,16). The percent
change of APV from rest to l-min of LBNP exposure at
-30 mm Hg was used to compare peripheral vascular
responses belore and alter simulated weightlessness.
Heart rate was measured continuously during the LBNP
test with a Hewlett Packard monitor (model 78203A). Sys-
tolic (SBP) and diastolic (DBP) blood pressures were re-
corded each 30-s of the LBNP test with an L.M. Electronics
automated system (model BAA-40W). Microphone record-
ings of Korotkoft'sounds I and IV were superimposed upon
a calibrated descending brachial cuff ramp. These sounds
were transcribed to identify systolic and diastolic blood
pressures, respectively. Mean arterial pressure (MAP) was
calculated by dividing the sum of SBP and twice DBP by
three.
On the day lbreceding bedrest and at the end of bedrest,
each subject exercised in a supine posture up to peak level
of oxygen uptake. A Collins electronic cycle ergometer was
rotated backward 90* and attached to a ventilated exercise
bed that allowed nearly complete exposure of skin tbr
evaporative heat loss. Exercise consisted of a 3-rain warmup
at zero watts followed by 15-W increments in load each
minute up to a self-determined endpoint of fatigue. Subjects
breathed through an Otis-McKerrow respiratory valve,
while the volume of expired gases was measured with a
Parkinson-Cowan high-velocity, low-resistance flowmeter.
Expired gas samples were drawn from a mixing chamber
and analyzed tbr oxygen and carbon dioxide with a Perkin-
Elmer mass spectrometer. Oxygen uptake was measured at
30-s intervals in all exercise tests.
Body fat was determined by underwater densitometry
(1 I) on day 7 of the prebedrest control period and at the
end of bedrest. Plasma volume was measured before and
after bedrest using a modified Evans blue dye dilution
method (8). Total blood volume was calculated from hem-
atocrit and plasma volume measurements. The blood drawn
prior to LBNP was analyzed for plasma norepinephrine by
the technique described by Henry et al. (9).
The data were analyzed with two-way analysis of variance
and two-tailed paired t-test statistics. The null hypothesis
was rejected when p values were less than 0.05.
RESULTS
Adaptations to 10 d of simulated weightlessness are pre-
sented in Table I. Mean body weight and body fat were
unaffected by bedrest. Peak oxygen uptake was reduced by
TABLE !. ADAPTATIONS TO SIMULATED WEIGHTLESSNESS.
Variable PreBR PostBR
Total Body Weight, kg 74.9 ± 2.5 74.8 ± 2.3
Body Fat Content, kg 13.0 ± I.I 13.5 ± 1.1
Plasma Volume, ml 3407 ± 126 2862 ± 103"
Blood Volume, ml 5646 ± 207 4847 ± 186"
Resting Plasma NE, pg,/ml 189 ± 15 232 ± 36
Peak Oxygen Uptake, L.min -L 2.84 ± .18 2.40 ± .14"
LBNP Tolerance, min 13.4 ± 1.4 9.8 ± 1.6"
Values are mean ± S.E.
* p < 0.05 vs. pre bcdrest.
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TABLE II. MEAN ARTERIAL PRESSURE, HEART RATE, AND ARTERIAL PULSE VOLUME OF THE LEGS DURING
REST (PreLBNP) AND AT I MIN OF -30 TORR LBNP BEFORE AND AF'I'ER BEDREST.
Before Bedrest After Bedrest
PreLBNP -30 mm tlg Percent Change PreLBNP -30 mm ltg Percent Change
Mean Arterial Pressure, mm Hg 87 ± 3 85 ± 2 -I.8 ± 1.8 93 :t: 2' 89 ± 3 -4.5 ± 1.4
Heart Rate, bpm 55 ± 1 61 ± 2* +11.4 ± 3.8 58 ± 3 69 :i: 3*t +18.1 ± 3.0 t
Arterial Pulse Volume, ml 6.9 ± 1.4 5.4 ± 1.2" -21.4 ± 3.4 5.9 ± 1.3"1" 4.6 ± 1.2*t -20.5 ± 2.7
Values are mean ± S.E.
* p < 0.05 vs. corresponding PreLBNP value.
p < 0.05 vs. corresponding value before bedrest.
15.5% (p < 0.05); and peak exercise heart rate was increased
(p < 0.05) from 171 + 13 bpm before bedrest to 179 -t- 13
bpm after bcdrest. Blood volume decreased by 14.2%
(p < 0.05) as a result of plasma volume reduction of 58 I
ml (-17.0%, p < 0.05). Resting plasma norepinephrine
levels were not significantly altered, but tol.erance to LBNP
in minutes was decreased by 26.9% (p < 0.05).
Resting heart rate was unaffected by bedrest (Table I1).
However, the rise in heart rate during 1 min of LBNP at
-30 mm Hg was greater (p < 0.05) after bedrest compared
to prebedrest. Bedrest had no significant effect on MAP
response to 1 min of-30 mm Hg LBNP.
APV was significantly decreased by 1 rain of exposure to
-30 mm Hg LBNP both before and after bedrest (Table I1).
The level of APV (in milliliters) was significantly decreased
after bedrest during rest and at 1 rain of-30 mm Hg LBNP.
Prior to bedrest, resting APV was 6.9 _ 1.4 ml. Alter
bcdrest, resting APV was 5.9 _ 1.3 ml (-14.8%, p < 0.05).
At 1 min of-30 mm Hg LBNP, APV was 5.4 + i.2 ml
before bedrest and 4.7 _ 1.2 ml (- 13.3%, p < 0.05) follow-
ing bedrest. APV was decreased (p < 0.05) from rest to -30
mm Hg LBNP to the same relative magnitude belbre and
alter bedrest (-21.4 ___3.4% and -20.5 _ 2.7%, respec-
tively).
DISCUSSION
As in previous investigations (4-6,19), 10 d of constant
chronic 6* head-down bedrest reduced plasma and blood
volume, peak oxygen uptake, and orthostatic tolerance.
Furthermore, greater elevation in heart rate was required
after bedrest to maintain similar levels of arterial pressure
during mild orthostasis induced by -30 mm Hg LBNP
compared to prebedrest conditions.
One mechanism that may contribute to inadequate car-
diovascular responses to orthostatie stress tbllowing simu-
lated weightlessness may be less arterial constriction due to
attenuated peripheral adrenergic receptor function. Dickey
et al. (7) observed a significant 45.7% reduction in diastolic
arterial pressure associated with phenylephrine treatment
after 14 d of horizontal casting in nonhuman primates.
These data indicated peripheral vascular alpha-adrencrgic
function was reduced lbllowing hypokinesia in these ani-
mals. Ifalpha-adrenoceptor responsiveness was reduced with
bedrest, we would have predicted less reduction in APV of
the legs during LBNP after bedrest. However, we found that
the magnitude of total vascular response in the legs was not
altered in humans by s_mulated weightlessness, as indicated
by the similar (21%) reduction in the percent change of leg
APV during exposure to LBNP before and after bedrest.
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Our results may, therefore, suggest that alpha-receptor re-
sponsiveness is not altered by simulated weightlessness.
Melada el al. (14) have susgested that increased vascular
beta-receptor sensitivity may contribute to inadequate or-
thostatic stress tolerance following simulated weightlessness,
since they found an increased tolerance to postbedrest tilt
with beta-receptor blockade. If beta-receptor responsiveness
was increased following simulated weightlessness, we would
have predicted a greater APV in the legs during LBNP
following bedrest. However, we Iound that from rest to I
min of-30 tort LBNP, leg APV decreased by the same
relative magnitude before and after bedrest. These data,
therefore, suggest that beta-receptor responsiveness was not
increased following bedrest. However, a limitation to our
study was that we did not utilize pharmacological agents to
verify specific alterations in alpha- and beta-adrenergic re-
ceptors following simulated weightlessness. Therefore, fur-
ther investigation is needed to identify the contribution of
specific adrenoreceptors to the leg vasculature response to
orthostasis following prolonged exposure to microgravity.
In any case, the net effect of 10 d of exposure to simulated
weightlessness was no alteration in total vasoconstrictive
response of the leg vaseulature.
Another finding in our study was a reduced leg APV
during rest tbllowing bedrest. One possible explanation for
this Iinding is an increased alpha-adrcnorcccptor respon-
siveness, since a similar level of resting catecholamines
observed in our study following bedrest was associated with
greater vasoconstriction during rest. However, since the
percent decrease in APV from rest to I rain of-30 torr
LBNP was similar betbre and after bedrest, we suggest that
increased vascular smooth muscle responsiveness during
orthostasis following simulated weightlessness was unlikely.
Our hypothesis is supported by Chobanian et al. (4), who
found that the response of mean arterial pressure to graded
infusions of norepinephrine, which stimulates both alpha-
and beta-receptors, was not altered by bedrest. An alterna-
tive explanation tbr the reduction in leg APV during rest
following simulated weightlessness may be a myogenic re-
sponse to a lower vascular volume associated with the
observed 14% decrease in blood volume.
An implication of our study is that no apparent alteration
in leg vascular smooth muscle responsiveness occurs during
acute orthostatie provocation after bedrest. Therefore, our
results suggest that the inability to sustain arterial pressure
following reentry from spaceflight is probably not a result
of ineffective reduction in peripheral vasoconstriction. The
findings of Melada et al. (14) suggest that specific pharma-
cological agents (e.g. propranolol) may act as effective coun-
termeasures against orthostatic intolerance following
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bedrest. A practical application of our findings is that phar-
macological agents acting on alpha- and beta-receptors of
the peripheral vasculature may not provide any significant
overall effect on the mechanisms controlling local peripheral
resistance following spaceflight, since these responses were
not affected by 10 d of bedrest.
The primary finding of our study was that there was no
apparent alteration in total leg vascular smooth muscle
responsiveness during acute orthostatic stress following sim-
ulated weightlessness. However, a myogenic response of
vascular smooth muscle to lower vascular fluid volume
associated with a plasma volume reduction may account for
a higher baseline vascular constriction during rest which, in
turn, may act to defend against loss in total systemic resis-
tance following spaceflight. Finally, we suggest that phar-
macological agents acting on the peripheral vasculature may
not be effective countermeasures for orthostatic intolerance
following prolonged exposure to actual or simulated weight-
lessness.
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